Walleye Trading’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,945
| Closed | -$221K | – | 4782 |
|
|
2020
Q1 | $170K | Buy |
+1,945
| New | +$206K | ﹤0.01% | 2748 |
|
|
2019
Q4 | – | Sell |
-339
| Closed | -$38K | – | 4770 |
|
|
2019
Q3 | $39K | Buy |
+339
| New | +$51.5K | ﹤0.01% | 3644 |
|
|
2019
Q1 | – | Sell |
-7,286
| Closed | -$1.08M | – | 4996 |
|
|
2018
Q4 | $710K | Buy |
+7,286
| New | +$956K | 0.01% | 2113 |
|
|
2018
Q3 | – | Sell |
-4,070
| Closed | -$587K | – | 5671 |
|
|
2018
Q2 | $568K | Buy |
4,070
+3,415
| +521% | +$485K | ﹤0.01% | 2719 |
|
|
2018
Q1 | $74K | Buy |
+655
| New | +$82.4K | ﹤0.01% | 4023 |
|
|
2017
Q4 | – | Sell |
-2,157
| Closed | -$253K | – | 4761 |
|
|
2017
Q3 | $219K | Buy |
2,157
+1,361
| +171% | +$146K | ﹤0.01% | 3159 |
|
|
2017
Q2 | $80K | Buy |
+796
| New | +$85.7K | ﹤0.01% | 3666 |
|
|
2017
Q1 | – | Sell |
-485
| Closed | -$59.5K | – | 5318 |
|
|
2016
Q4 | $54K | Buy |
+485
| New | +$58.4K | ﹤0.01% | 3604 |
|
|
2016
Q2 | – | Sell |
-3,387
| Closed | -$285K | – | 5879 |
|
|
2016
Q1 | $244K | Buy |
+3,387
| New | +$186K | ﹤0.01% | 2616 |
|
|
2015
Q4 | – | Sell |
-1,145
| Closed | -$93.3K | – | 5880 |
|
|
2015
Q3 | $105K | Buy |
1,145
+503
| +78% | +$55.9K | ﹤0.01% | 2911 |
|
|
2015
Q2 | $79K | Buy |
+642
| New | +$72.8K | ﹤0.01% | 3207 |
|
Other funds holding GWPH
Walleye Trading's GWPH Position: Q2 2020 in Review
Walleye Trading sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2020, closing a stake of 1,945 shares — an estimated $221K sold.
Walleye Trading first reported a position in GWPH in Q2 2015 and held it in 11 quarters. The position peaked at $710K in Q4 2018. 299 funds tracked by Wall St. Rank hold GWPH as of Q2 2020.
- Walleye Trading reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2020 after selling out during the quarter.
- Walleye Trading sold 1,945 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2020, an estimated $221K.
- Walleye Trading first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2015 and held it in 11 quarters.
- Walleye Trading's GW Pharmaceuticals Plc American Depositary Shares position peaked at $710K in Q4 2018.
- 299 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2020.
Based on Walleye Trading's 13F filing for Q2 2020, filed 14 Aug 2020.